⌘K

Login Start Free

Home/Filings/4/0000864268-04-000074

4//SEC Filing

DANIEL C RALPH III 4

Accession 0000864268-04-000074

CIK 0000864268other

View on SEC.gov Company Profile

Filed

Aug 10, 8:00 PM ET

Accepted

Aug 11, 10:34 AM ET

Size

14.9 KB

Accession

0000864268-04-000074

Insider Transaction Report

Form 4

Period: 2004-06-15

BRADLEY PHARMACEUTICALS INCBDY

DANIEL C RALPH III

Director

Transactions

Discretionary Transaction
Stock Options (Right to buy)
2004-06-15$25.75/sh+1,009$25,982→ 2,017 total
Exercise: $25.75From: 2006-06-15Exp: 2014-06-14→ Common Stock (1,009 underlying)
Discretionary Transaction
Stock Options (Right to buy)
2004-06-15$25.75/sh+658$16,944→ 2,675 total
Exercise: $25.75From: 2005-06-15Exp: 2014-06-14→ Common Stock (658 underlying)
Discretionary Transaction
Stock Options (Right to buy)
2004-06-15$25.75/sh+1,008$25,956→ 1,008 total
Exercise: $25.75From: 2005-06-15Exp: 2014-06-14→ Common Stock (1,008 underlying)
Discretionary Transaction
Stock Options (Right to buy)
2004-06-15$25.75/sh+1,667$42,925→ 5,000 total
Exercise: $25.75From: 2007-06-15Exp: 2014-06-14→ Common Stock (1,667 underlying)

Holdings

Stock Options (Right to buy)
Exercise: $16.61From: 2006-06-19Exp: 2013-06-18→ Common Stock (15,000 underlying)
15,000

Documents

1 file

4
c0001252753d20040811f4f.xmlPrimary
PRIMARY DOCUMENT

Issuer

BRADLEY PHARMACEUTICALS INC

CIK 0000864268

Entity typeother

Related Parties

1

filerCIK 0001252753

Filing Metadata

Form type: 4
Filed: Aug 10, 8:00 PM ET
Accepted: Aug 11, 10:34 AM ET
Size: 14.9 KB

View on SEC.gov